Article Tools UNDERSTANDING THE PATHWAY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2011.38.7167 Journal of Clinical Oncology - published online before print December 12, 2011 PMID: 22162582 Phosphatidylinositide-3-Kinase Inhibitors: Addressing Questions of Isoform Selectivity and Pharmacodynamic/Predictive Biomarkers in Early Clinical Trials Paul A. ClarkexPaul A. ClarkeSearch for articles by this author , Paul WorkmanxPaul WorkmanSearch for articles by this author Show More The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey, United Kingdom https://doi.org/10.1200/JCO.2011.38.7167 First Page Full Text PDF Figures and Tables © 2011 by American Society of Clinical Oncology
No takes yet. Share an insight, caveat, or question.
Clarke et al. (2011) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: